Cases 31 - 40 of 125
Merck Sharp & Dohme Corp. et al v. Hetero Labs Limited et al
as 1:2022cv00378
Plaintiff:
Merck Sharp & Dohme Corp., MSD International Business GmbH, MSD International GmbH and others
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI CO., LTD. et al v. HETERO USA INC. et al
as 1:2022cv01795
Plaintiff:
EISAI CO., LTD., EISAI INC. and NOVARTIS PHARMA AG
Defendant:
HETERO USA INC., HETERO LABS LIMITED and HETERO LABS LIMITED UNIT-III
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Hetero USA Inc. et al
as 1:2021cv01760
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Hetero USA Inc., Hetero Labs Limited and Hetero Labs Limited Unit III
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Lupin Limited, et al
as 1:2018cv00088
Counter Defendant:
Takeda Pharmaceutical Company Ltd.
Plaintiff:
Takeda Pharmaceuticals International AG, H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Apotex Inc., Apotex Research Private Limited, Apotex Corp. and others
Counter Claimant:
Unichem Laboratories, Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2021cv01330
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alkem Laboratories Ltd., Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. et al v. Annora Pharma Private Limited et al
as 1:2020cv00122
Defendant:
Annora Pharma Private Limited, Hetero Labs Limited and Hetero USA, Inc.
Plaintiff:
Amgen Inc. and Les Laboratoires Servier
Cause Of Action: 35 U.S.C. § 1
Duchesnay Inc. et al v. Hetero Labs Limited et al
as 1:2021cv01130
Plaintiff:
Duchesnay Inc., Shionogi Inc. and QuatRx Pharmaceuticals Company
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero Drugs Limited and others
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc. et al v. Hetero Labs Limited et al
as 1:2021cv01063
Plaintiff:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Defendant:
Hetero Labs Limited and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
